Quantcast

Posts related to ‘Biogen Idec’

pills

Lou Gehrig’s Disease Drug Failure Crushes Biogen Idec

Biogen Idec Inc. (NASDAQ: BIIB) is living up to why we just said it is now an overvalued biotech stock for 2013. Biogen Idec and the other biotech giants had risen perhaps too ...
Read Full Story »